When Genomics England began back in 2013, the very idea that we could sequence 100,000 genomes was an audacious one. No-one had ever done it before. And, if the technical challenge wasn’t enough, there was also an NHS transformation project to deliver, which would, if everything worked out, be the basis for a new NHS Genomic Medicine Service. Finally, for good measure, there was the development of a major research facility, which could turn genomic information into new knowledge,
A Shared Journey of Discovery – Jillian Hastings Ward reflects on the fifth anniversary of Genomics England’s Participant Panel
We’d love you to join the Participant Panel! Can you come to the first meeting, on Monday?
So began a personal adventure, better than I ever imagined, with a group of people who continue to inspire me on a weekly basis. From a genetics appointment in London, to addressing conference audiences in San Diego and Melbourne; from parenting a severely disabled child with an undiagnosed condition, to helping establish a global community of families like us.
International Women’s Day 2021 blog: Baroness Nicola Blackwood celebrates women involved in the fight against COVID-19
Exactly three months ago, 90-year-old grandmother Margaret Keenan became the first person in the world to receive a COVID-19 vaccine. This landmark event, a major turning point in the battle against the virus, came less than a year after the first recorded coronavirus case in the UK. A remarkable feat of endeavour by science and healthcare.
Margaret’s story is the culmination of an unparalleled journey by the global health and scientific community, who have so admirably fought back against a disease about which we knew so little this time last year.
On International Women’s Day, Dr Christine Patch, Clinical Lead for Genetic Counselling at Genomic England, talks about stepping into the role of Genomics England’s Caldicott Guardian, and pays tribute to the first National Data Guardian, Dame Fiona Caldicott.
The sad news of Dame Fiona Caldicott’s passing last month caused an outpouring of gratitude from around the health and social care sector. Dame Fiona’s vision was that everyone should be able to trust that their personal confidential data is protected and being used appropriately.
Genomics England is excited to announce the appointment of Andrew Eland, Annalisa Jenkins and Vikram Bajaj to the Board as Non-Executive Directors.
Andrew Eland, CEO and Founder of Diagonal Work
Andrew, a software engineer by trade, has spent time working with Google, DeepMind and, more recently, Diagonal Work. He originally joined Google in 2005, working predominantly on Google Maps, and was appointed as Engineering Director in 2010. He left four years later to take up another Engineering Director position,
My daughter was born prematurely and at around 8 months old, she seemed to regress in her development and started making strange jack-knife movements at certain times of the day. She was diagnosed at Addenbrooke’s hospital in Cambridge with a rare and severe form of epilepsy called West syndrome. West syndrome diagnosis is based around the child having very specific and irregular brainwaves, developmental regression and seizures. Luckily, our clinician was actively involved in a clinical trial for treating West syndrome.
LifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19
Medical research charity, LifeArc, announces today that it is providing £5 million funding to support the work of the GenOMICC COVID-19 Study, led by the GenOMICC consortium in partnership with Genomics England. The study, launched in May 2020, is using genomics to investigate why some people are affected more severely by COVID-19, and increase our understanding about the disease.
GenOMICC is a global collaboration of doctors and scientists working together to understand and treat serious illnesses,
International Day of Women and Girls in Science: Vivienne Parry celebrates geneticist Barbara McClintock
Thinking about Women in STEM this week has made me want to introduce Barbara McClintock to you. She brings together two parts of my life, my undergraduate years taking genetics and my time at Genomics England. She may not be very familiar to many of you, yet what she discovered underpins everything we do here.
She was the first and so far, only woman to have won the Nobel Prize for Physiology or Medicine unshared.
In this blog, Chris Wigley, CEO of Genomics England, tells us in his own words why it is so important for us to talk to as many people as possible about genomics, and why we have launched our podcast, The G Word.
I’ve spent my career at the intersection of technology, ethics and human stories. Now, I lead the amazing team here at Genomics England. We’re trying to bring the benefits of genomic medicine to everyone,
This week, Genomics England has launched its first company podcast. ‘The G Word’ will be hosted by Chris Wigley, our CEO, who will talk to a wide variety of people about all things genomics, with the aim of making the topic more accessible and understandable to all.
Most people understand that our DNA is the blueprint that lies at the heart of our cells and bodies. Many people have done mail-order genetic tests to explore their heritage,
In September 2020, the UK Government published Genome UK, a vision for the next ten years of genomic healthcare. This National Genomic Healthcare Strategy sets out a plan to deliver the future of care in the NHS by enabling the provision of world-leading genomic healthcare to patients in the UK and across the world.
Over the next 10 years, the Government’s ambition is to create the most advanced genomic healthcare system in the world,
The National Genomic Research Library (NGRL) now contains one of the richest genomic datasets in the world for both rare disease and cancer research, following the curation and addition of all consented genomes from the 100,000 Genomes Project. The Library now holds the data of over 110,000 clinically linked genomes, from over 97,000 participants.
This latest data update to the Genomics England Research Environment, the platform to access the NGRL, is a major milestone for the 100,000 Genomes Project as well as future research.
Health and Social Care Secretary Matt Hancock has today heralded the launch of a landmark new strategy which will secure the UK’s future position as a global leader in genomics.
The new National Genomic Healthcare Strategy – Genome UK – will ensure the UK can offer patients the best possible predictive, preventative and personalised care by harnessing the potential of advanced genome sequencing.
The strategy sets out how the UK genomics community – from researchers through to the NHS – will come together to harness the latest advances in genetic and genomic science,
Baroness Dido Harding has decided to step down from the Board of Genomics England with immediate effect, to concentrate on her role as interim Chair of the newly formed National Institute for Health Protection, as well as her on-going role as Chair of NHS Improvement.
We’re hugely grateful to Dido for her contribution to Genomics England, for sharing her knowledge and experience during her time on the Board, and also for her direction and counsel during her time as our interim Chair.
The Chair of Genomics England is calling on young women across the United Kingdom to follow in the footsteps of Rosalind Franklin, a British chemist and X-ray crystallographer who played a key role in the discovery of DNA, and whose centenary is being celebrated today.
Baroness Nicola Blackwood, a former Minister for Life Sciences at the Department of Health and Social Care (DHSC), paid tribute to Franklin, whose contribution to discoveries about DNA made possible the sequencing of the human genome,
British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments
Genomics England (GEL) has today launched a next-generation genomic research platform that will play a key role in the research response to COVID-19. This ground-breaking research environment will transform how genomic data is made usable for global biopharma and academic researchers. It will provide world-class patient data security,
In this opinion piece, Chris Wigley, CEO of Genomics England, shares his reflections on the 20th anniversary of the first genome to be sequenced.
Not for a century has the world witnessed a pandemic on anything approaching the scale of COVID-19. Millions have been infected, almost half a million have died, economies have been shut down, jobs lost, schools closed, families divided, and civil liberties restricted to levels unknown outside war time.
A novel system which will allow rare disease patients and their caregivers to add additional information about themselves to research databases is being developed by Sano Genetics in collaboration with Zetta Genomics and Genomics England. The system will add an important layer of patient derived information to the groundbreaking precision medicine research being carried out through Genomics England. The information provided by individuals may be reported by participants directly, for example daily symptom tracking,
- Genetic susceptibility to coronavirus to be tested in ground-breaking nationwide study
- Genomes of thousands of patients with coronavirus will be sequenced to understand how a person’s genetic makeup could influence how they react to the virus
- Genomics England partners with University of Edinburgh to lead research drive to support the search for new treatments
Baroness Nicola Blackwood has been appointed Chair of Genomics England, succeeding Baroness Dido Harding, who has served as Interim Chair since November 2019.
Genomics England was established in 2013 to deliver the 100,000 Genomes Project in partnership with the NHS and helped to cement the UK’s world-leading position in genomic science. Following the successful sequencing of 100,000 whole genomes in December 2018, Baroness Blackwood will support Genomics England through its next phase of development,